The genetics and biology of KRAS in lung cancer

Cited by (116)

Items 101–116 of 116

1. A novel role for RASSF1A in the regulation of RAS activation.
   Desmond Harrell Stewart · 2020 · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
2. KRAS G12C-Mutant Non-Small-Cell Lung Adenocarcinoma: First Documented Report in the Arabian Gulf
   Abdullah S Alsulaiman, Siraj B. Alharthi, Ahmed S Albariqi, Rasha A Mutabaqani, Fawzi Faisal Bokhari, Islam M. Tayeb, Dalia R Alharthi, Muhammad Usman Tariq, Yasser H Babaier · 2022 · Cureus
3. KRAS Association with Lung Cancer: An Overview
   Shaifaly Madan Rustagi, Panav Rustagi · 2022 · Journal of Medical Academics
4. Effects of Thymoquinone and Cisplatin on C-MYC, KRAS, p53 and EGFR Gene Expression in Lung Cancer Cell Lines
   Bayrakçı Onur, Demet Taşdemir Kahraman, Sedat İlhan, Işik Ahmet Ferudun · 2022 · Journal of Cancer and Tumor International
5. Exploring the Genetic Differences Between Small Cell and Non-small Cell Lung Cancer Using Bioinformatic Approaches: A Preliminary Study
   Muhammad Amru Nazri, Faris Aizat Ahmad Fajri, Muhamad Harith Zulkifli, Fazlin Mohd Fauzi · 2022 · Atlantis Highlights in Chemistry and Pharmaceutical Sciences/Atlantis highlights in chemistry and pharmaceutical sciences
6. Vitamin D Deficiency in Smokers: A Major Risk Factor in Lung Carcinogenesis
   Subendu Sarkar, Manas Kamal Sen, Rajender Pal Singh, Gorachand Bhattacharya · 2025 · Qeios
7. Vitamin D Deficiency in Smokers: A Major Risk Factor in Lung Carcinogenesis
   Subendu Sarkar, Manas Kamal Sen, Rajender Pal Singh, Gorachand Bhattacharya · 2025 · Qeios
8. Vitamin D Deficiency in Smokers: A Major Risk Factor in Lung Carcinogenesis
   Subendu Sarkar, Manas Kamal Sen, Rajender Pal Singh, Gorachand Bhattacharya · 2025 · Qeios
9. Assessing mutation-clinical correlations and treatment outcomes in Vietnamese non-small cell lung cancer patients
   Hoang-Bac Nguyen, Suong Thi-Bang Nguyen, Huu-Huy Nguyen, Minh-Khoi Le, Quoc-Trung Lam, Anh Tuấn Nguyễn · 2025 · Practical Laboratory Medicine
10. Comprehensive computational analysis of PKCδ non-synonymous variants identifies rs1703863535 as a potential breast cancer biomarker
    Sameen Zafar, Yasmin Badshah, Maria Shabbir, Somia Khan, Amna Hafeez, Naeem Mahmood Ashraf, Janeen H. Trembley, Tayyaba Afsar, Ali Madi Almajwal, Suhail Razak · 2025 · BMC Cancer
11. RNA interference via lipid nanoparticles: An innovative perspective for the treatment of non-small cell lung cancer
    Gabriela Thomazotti Estevez Claro Roberto, Jéssica Fagionato Masiero, Marco Antônio Stephano, Nádia Araci Bou‐Chacra · 2026 · Journal of Drug Delivery Science and Technology
12. Rôle des lymphocytes B associés aux structures lymphoïdes tertiaires dans la réponse clinique des patients atteints d’un cancer pulmonaire
    Hélène Kaplon · 2018 · theses.fr (ABES)
13. Genetic biomarkers in cancer
    Harpreet Singh, Arun Kumar Mishra, Vivek Kumar, Km. Pinki, Arvind Kumar, Amrita Mishra, Amit Kumar Anand · 2026 · Elsevier eBooks
14. Computational identification and characterization of high-risk human KRAS nsSNPs: Impacting structure, ligand binding, and cancer prognosis
    Md. Mainuddin Hossain, Juthi Adhikari, Sabbir Ahmed, Md. Zakiul Islam Zaki, Afia Khandaker, Abu Zaffar Shibly · 2026 · Journal of Genetic Engineering and Biotechnology
15. Oncogenic KRAS in Cancer Immunotherapy: From Oncogenic Signaling to Tumor-Immune Ecosystem Regulation
    Milad Ashrafizadeh, Noushin Nabavi, Yifei Xu · 2026 · Cancer Biome and Targeted Therapy
16. α- and γ-Mangostins Suppress KRAS-Associated Signaling Pathways and Inhibit the Growth of Human Lung Cancer Cells
    Ji Yun Lee, Ji-Young Hong, Young‐Won Chin, Sang Kook Lee · 2026 · Natural Product Sciences